Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-10-14, Stock:LLY, The news for the past five days is as follows:
2020-10-07: NEWS1: US STOCKS-Wall Street ends higher on hope that partial coronavirus stimulus deal may occur.NEWS2: US STOCKS-Wall Street closes higher on hope that partial coronavirus stimulus deal may occur.NEWS3: BUZZ-U.S. STOCKS ON THE MOVE-Workday, Stable Road Acquisition, RedHill Biopharma, Fox Corp, Disney.NEWS4: US STOCKS-Wall Street jumps on hopes for piecemeal stimulus deal.NEWS5: Eli Lilly Requests Emergency Use Authorization for COVID-19 Treatment Candidate.NEWS6: US STOCKS-Wall St bounces on hopes for piecemeal stimulus deal.NEWS7: BUZZ-U.S. STOCKS ON THE MOVE-United Airlines, CleanSpark, Netflix, TransEnterix, Peck Company.NEWS8: Wall Street rises, shaking off Trump's stimulus shock.NEWS9: Eli Lilly Submits Initial Request For Emergency Use Authorization To Treat COVID-19 .NEWS10: Eli Lilly seeks U.S. FDA emergency use tag for COVID-19 antibody treatment.NEWS11: Why Sorrento Therapeutics Stock Bolted Higher in September.NEWS12: US STOCKS-Wall St set to rise, shaking off Trump's stimulus shock.NEWS13: Eli Lilly applies for FDA emergency use authorization for COVID-19 treatment.
2020-10-08: NEWS1: Lilly Confirms Date and Conference Call for Third-Quarter 2020 Financial Results Announcement.NEWS2: Covid Report: Regeneron Pharmaceuticals Files For Emergency Authorization; Gilead Inks European Supply Deal.NEWS3: Best COVID Drug Stocks to Buy on Trump Recovery.NEWS4: Coronavirus Latest: Thursday, October 8.NEWS5: Regeneron Requests Emergency Use Authorization, Analysts See Coronavirus Antibodies As Earnings Driver In 2021.NEWS6: Regeneron needs to provide more data on its antibody therapy: Emergency Physician.NEWS7: BUZZ-U.S. STOCKS ON THE MOVE-Occidental Petroleum, Oxbridge Re Holdings, Roku, fuboTV, Beyond Meat.NEWS8: Lilly's rheumatoid arthritis drug cuts COVID-19 deaths in trial, data shows.NEWS9: Lilly's rheumatoid arthritis drug cuts COVID-19 deaths in trial, data shows.NEWS10: The Truth About Trump's Covid-19 Cocktail ‘Cure’.NEWS11: Coronavirus update: Regeneron, Eli Lilly seek FDA approval of antibodies, boosted by Trump's bout with COVID.NEWS12: Fauci says "reasonably good chance" Regeneron antibody therapy helped Trump.NEWS13: BUZZ-U.S. STOCKS ON THE MOVE-Corteva, Martin Marietta Materials, Tesla, Acuity Brands, Dana Inc.NEWS14: Trump urges for emergency authorization of Regeneron, Eli Lilly COVID-19 therapies.NEWS15: Baricitinib has Significant Effect on Recovery Time, Most Impactful in COVID-19 Patients Requiring Oxygen.NEWS16: Noteworthy ETF Inflows: MTUM, AMZN, LLY, DHR.NEWS17: Lilly provides comprehensive update on progress of SARS-CoV-2 neutralizing antibody programs.NEWS18: BUZZ-U.S. STOCKS ON THE MOVE-Medtronic, Carnival, JetBlue Airways, Bausch Health, Gilead, Cytokinetics.NEWS19: Regeneron Pharmaceuticals Seeks Emergency Approval From FDA.NEWS20: Regeneron Wants FDA Approval for Trump’s Covid-19 Treatment. What Could Come Next..NEWS21: US STOCKS-Wall St rises on stimulus prospects as jobless claims remain high.NEWS22: BUZZ-U.S. STOCKS ON THE MOVE-Eaton Vance, IBM, Domino's Pizza, Jazz Pharma, Moderna, American Airlines.NEWS23: US STOCKS-Wall St set to rise on stimulus hopes as jobless claims stay elevated.NEWS24: Fosun unit to begin U.S. trial of COVID-19 antibody treatment soon.NEWS25: Lilly, Gates Foundation To Supply Potential COVID-19 Therapy For Low, Middle Income Countries .NEWS26: Eli Lilly in deal to supply COVID-19 treatments to low income countries.NEWS27: BUZZ-U.S. STOCKS ON THE MOVE-JetBlue Airways, Regeneron, Newpark Resources, Graham Corp.NEWS28: /R E M I N D E R -- Media Advisory - Prime Minister's itinerary for Thursday, October 8, 2020/.NEWS29: CDNA, OCUL Soar On Prelim Q3 Revenue, Lilly Seeks EUA For LY-CoV555 In COVID-19, ALKS On Watch .NEWS30: Regeneron antibodies in demand after Trump treatment, doctors seek more data.
2020-10-09: NEWS1: President Trump getting Regeneron treatment is 'wrong and unethical': Dr. Ezekiel Emanuel.NEWS2: Coronavirus Latest: Friday, October 9.NEWS3: Top Analyst Reports for Mastercard, JPMorgan & Eli Lilly.NEWS4: Pharma Stock Roundup: LLY, AZN, PFE, GSK Progress on Coronavirus Programs.NEWS5: Eli Lily: Intriguing COVID-19 Story, but Questions Remain.NEWS6: HHS expects over 1 mln antibody doses from Regeneron, Lilly in 2020.NEWS7: Should You Invest in Regeneron, Lilly, or Gilead?.NEWS8: Need More Proof That Gilead’s Treatment Helps Covid Patients? You Just Got It..NEWS9: Lilly's OVERCOME Study Reveals Nearly 80% of People Reported Improvement in Their Migraine Since Starting a CGRP Monoclonal Antibody for Preventive Treatment.
2020-10-12: nan
2020-10-13: nan

Answer: Decrease